Hope for new peanut allergy treatment
Syracuse, N.Y. —
A California drug company has developed a daily capsule containing peanut flour, which seems to de-sensitize children to nuts.
The company is Aimmune Therapeutics and they said that 67 percent of kids who had the treatment were eventually able to tolerate small amounts of peanuts.
The drug still needs more research, but the company is planning to file for approval by the F-D-A by the end of the year.
Adam Herringshaw is the father of nine-year-old Janna, who suffers from a peanut allergy.
"Managing each and every day is not an easy thing to do," Herringshaw said.
Luckily, it's been seven years since Janna had an attack, but it's definitely still a concern for their family. He is hoping Janna never has to go through a reaction again. When she is having a reaction to peanuts, her skin could turn red, she could have hives, and she could have shortness of breath.
He said as a parent he would have a difficult time giving his daughter the new capsule. He's still a little skeptical of the unknown, but may give it a try if more studies are done first.
"We as a family are extremely excited, we always hold hope that something will be developed to help Jan and others like her," Herringshaw said.
Since no specific treatment like this capsule have been approved yet, Adam and his family say they are constantly worrying about Janna's allergy.
When they go to grocery stores they spend a while reading the labels, making sure to avoid any products that may contain nuts. They also have to talk to restaurant workers, before they sit down.
He said Janna takes an Epipen with her wherever she goes, sometimes taking two. Janna described her experiences without an Epipen as, "scary."
They continue to hope for a better alternative to managing a peanut allergy.